# Moonwalk Biosciences, Inc. — Form D

Moonwalk Biosciences, Inc. of SOUTH SAN FRANCISCO, CA, a company, filed a Form D exempt-offering notice with the SEC on 2024-01-02. The offering totals $56.8M, of which $49.6M was reported sold. Industry: Biotechnology.

## Offering

- Filed: 2024-01-02
- Form: D
- Accession: 0002004362-24-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $56.8M
- Amount sold: $49.6M
- Remaining: $7.2M
- Investors: 24
- Date of first sale: 2023-12-18
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-501346

## Issuer

- Name: Moonwalk Biosciences, Inc.
- CIK: 0002004362
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 2 TOWER PLACE, 17TH FLOOR, SOUTH SAN FRANCISCO, CA, 94080
- Phone: 650-540-9709

## Officers, directors & promoters (5)

| Name | Role | Location |
| --- | --- | --- |
| Alexander Aravanis | Director | South San Francisco, CA |
| Arash Jamshidi | Director | South San Francisco, CA |
| Alexander Aravanis | Executive Officer | South San Francisco, CA |
| Arash Jamshidi | Executive Officer | South San Francisco, CA |
| Justin Keller Valley | Executive Officer | South San Francisco, CA |

## More

- [CIK 2004362 on SEC EDGAR (source of record)](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=2004362&type=&dateb=&owner=include&count=40)
- [This page as markdown (for LLM agents)](https://search.stillhousedata.com/formd/0002004362-24-000001.md)
- [Search all SEC filings, advisers and people on Adviser Search](https://search.stillhousedata.com/)

---

Source: public SEC filing data via Adviser Search (https://search.stillhousedata.com).
Agents: this data is also queryable via MCP tools and read-only SQL — see https://search.stillhousedata.com/llms.txt.